Recursion Pharmaceuticals Inc Clas (RXRX)
Cash & Short-Term Investments
$545.68M
Quarterly · Period ending: · USD
RXRX Cash & Short-Term Investments
Latest reported$743.29Mperiod ending
Latest reported$743.29Mperiod ending
RXRX FY Cash & Short-Term Investments ($69.88M → $743.29M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
RXRX cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 743,294,000 | |
| 594,350,000 | |
| 391,565,000 | |
| 549,912,000 | |
| 516,562,000 | |
| 262,126,000 | |
| 69,883,000 |